Peripheral venous congestion causes inflammation, neurohormonal, and endothelial cell activation

European Heart Journal

Volumn 35, Issue 7, 2014, Pages 448-454

  Colombo, Paolo C ^a   Onat, Duygu ^a   Harxhi, Ante ^a   Demmer, Ryan T ^b   Hayashi, Yacki ^a   Jelic, Sanja ^a   Lejemtel, Thierry H ^c   Bucciarelli, Loredana ^d   Kebschull, Moritz ^e   Papapanou, Panos ^a   Uriel, Nir ^a   Schmidt, Ann Marie ^f   Sabbah, Hani N ^g   Jorde, Ulrich P ^a  

^a NewYork Presbyterian Hospital   (United States)

^b Columbia University ^*  (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d IRCCS MULTIMEDICA   (Italy)

^e UNIVERSITY OF BONN   (Germany)

^f NEW YORK UNIVERSITY   (United States)

^g HENRY FORD HOSPITAL   (United States)

Author keywords

Congestive heart failure; Endothelin; Endothelium; Inflammation

Indexed keywords

CONGESTIVE HEART FAILURE; ENDOTHELIN; ENDOTHELIUM; INFLAMMATION;

ADULT; ANGIOTENSIN II; ARM; CYTOKINES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HEALTHY VOLUNTEERS; HEART FAILURE; HUMANS; HYPEREMIA; MALE; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; RNA, MESSENGER; VASCULAR CELL ADHESION MOLECULE-1; VASCULITIS;

EID: 84894249144     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht456     Document Type: Article

References (43)

1. Munger MA, Johnson B, Amber IJ, Callahan KS, Gilbert EM. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1996;77:723-727.
2. Testa M, Yeh M, Lee P, Fanelli R, Loperfido F, Berman JW, LeJemtel TH. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 1996;28:964-971.
3. Packer M. Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure? Circulation 1995;92:1379-1382.
4. Carlstedt F, Lind L, Lindahl B. Proinflammatory cytokines, measured in a mixed population on arrival in the emergency department, are related to mortality and severity of disease. J Intern Med 1997;242:361-365.
5. Matsumoto M, Tsujino T, Lee-Kawabata M, Naito Y, Sakoda T, Ohyanagi M, Masuyama T. Serum interleukin-6 and c-reactive protein are markedly elevated in acute decompensated heart failure patients with left ventricular systolic dysfunction. Cytokine 2010;49:264-268.
6. Barreto DV, Barreto FC, Liabeuf S, Temmar M, Lemke HD, Tribouilloy C, Choukroun G, Vanholder R, Massy ZA, European Uremic Toxin Work G. Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease. Kidney Int 2010;77:550-556.
7. Descamps-Latscha B, Herbelin A, Nguyen AT, Roux-Lombard P, Zingraff J, Moynot A, Verger C, Dahmane D, de Groote D, Jungers P et al. Balance between il-1 beta, tnf-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. relationships with activation markers of t cells, b cells, and monocytes. J Immunol 1995;154:882-892.
8. Rodeheffer RJ, LermanA,HeubleinDM,Burnett JCJr. Increasedplasmaconcentrations of endothelin in congestive heart failure in humans. Mayo Clin Proc 1992;67:719-724.
9. Cottone S, Mule G, Guarneri M, Palermo A, Lorito MC, Riccobene R, Arsena R, Vaccaro F, Vadala A, Nardi E, Cusimano P, Cerasola G. Endothelin-1 and f2-isoprostane relate to and predict renal dysfunction in hypertensive patients. Nephrol, Dial, Transplant 2009;24:497-503.
10. Dzau VJ, Colucci WS, Hollenberg NK, Williams GH. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation 1981;63:645-651.
11. PatonAM, LeverAF, OliverNW,MedinaA,Briggs JD,Morton JJ,BrownJJ, RobertsonJI, Fraser R, Tree M, Gavras H. Plasma angiotensin ii, renin, renin-substrate and aldosterone concentrations in acute renal failure in man. Clin Nephrol 1975;3:18-23.
12. Tsutamoto T, Hisanaga T, Fukai D,Wada A, Maeda Y, Maeda K, Kinoshita M. Prognostic value of plasma soluble intercellular adhesionmolecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure. Am J Cardiol 1995;76:803-808.
13. Andreassen AK, Nordoy I, Simonsen S, Ueland T, Muller F, Froland SS, Gullestad L, Aukrust P. Levels of circulating adhesion molecules in congestive heart failure and after heart transplantation. Am J Cardiol 1998;81:604-608.
14. Klein RM, Breuer R, Mundhenke M, Schwartzkopff B, Strauer BE. Circulating adhesion molecules (cicam-1, lcvcam-1) in patients with suspected inflammatory heart muscle disease. Z Kardiol 1998;87:84-93.
15. Yin WH, Chen JW, Jen HL, Chiang MC, Huang WP, Feng AN, Lin SJ, Young MS. The prognostic value of circulating soluble cell adhesion molecules in patients with chronic congestive heart failure. Eur J Heart Fail 2003;5:507-516.
16. BonominiM, Reale M, Santarelli P, Stuard S, SettefratiN, Albertazzi A. Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients. Nephron 1998;79:399-407.
17. Chin BS, Conway DS, Chung NA, Blann AD, Gibbs CR, Lip GY. Interleukin-6, tissue factor and von willebrand factor in acute decompensated heart failure: relationship to treatment and prognosis. Blood Coagul Fibrinolysis 2003;14:515-521.
18. Galatius S,Wroblewski H, Sorensen VB, Bie P, Parving HH, Kastrup J. Endothelin and von willebrand factor as parameters of endothelial function in idiopathic dilated cardiomyopathy: different stimuli for release before and after heart transplantation? Am Heart J 1999;137:549-554.
19. Shen L, Lu G, DongN, Jiang L,MaZ, Ruan C. Vonwillebrand factor, adamts13 activity, tnf-alpha and their relationships in patients with chronic kidney disease. Exp TherMed 2012;3:530-534.
20. Kawai M, Naruse K, Komatsu S, Kobayashi S, Nagino M, Nimura Y, Sokabe M. Mechanical stress-dependent secretion of interleukin 6 by endothelial cells after portal vein embolization: clinical and experimental studies. J Hepatol 2002;37: 240-246.
21. Wang BW, Chang H, Lin S, Kuan P, Shyu KG. Induction of matrix metalloproteinases-14 and-2 by cyclical mechanical stretch is mediated by tumor necrosis factor-alpha in cultured human umbilical vein endothelial cells. Cardiovasc Res 2003;59:460-469.
22. HasdaiD, HolmesDR Jr, Garratt KN, EdwardsWD,LermanA. Mechanical pressure and stretch release endothelin-1 from human atherosclerotic coronary arteries in vivo. Circulation 1997;95:357-362.
23. Delli Gatti C, Osto E, Kouroedov A, Eto M, Shaw S, Volpe M, Luscher TF, Cosentino F. Pulsatile stretch induces release of angiotensin ii and oxidative stress in human endothelial cells: effects of ace inhibition and at1 receptor antagonism. Clin Exp Hypertens 2008;30:616-627.
24. Ali MH, Pearlstein DP, Mathieu CE, Schumacker PT. Mitochondrial requirement for endothelial responses to cyclic strain: implications for mechanotransduction. Am J Physiol Lung Cell Mol Physiol 2004;287:L486-L496.
25. Cheng JJ, Wung BS, Chao YJ,Wang DL. Cyclic strain enhances adhesion of monocytes to endothelial cells by increasing intercellular adhesion molecule-1 expression. Hypertension 1996;28:386-391.
26. Galbusera M, Zoja C, Donadelli R, Paris S, Morigi M, Benigni A, Figliuzzi M, Remuzzi G, Remuzzi A. Fluid shear stress modulates von willebrand factor release from human vascular endothelium. Blood 1997;90:1558-1564.
27. Colombo PC, Ashton AW, Celaj S, Talreja A, Banchs JE, Dubois NB, Marinaccio M, Malla S, Lachmann J,Ware JA, Le Jemtel TH. Biopsy coupled to quantitative immunofluorescence: a new method to study the human vascular endothelium. J Appl Physiol 2002;92:1331-1338.
28. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of affymetrix genechip probe level data. Nucleic Acids Res 2003;31:e15.
29. Kuhn A, Thu D,Waldvogel HJ, Faull RL, Luthi-Carter R. Population-specific expression analysis (psea) reveals molecular changes in diseased brain. Nat Methods 2011;8: 945-947.
30. Storey JD, Tibshirani R. Statistical methods for identifying differentially expressed genes in DNA microarrays. Methods Mol Biol 2003;224:149-157.
31. Huang daW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44-57.
32. Kapadia S, Lee J, Torre-Amione G, Birdsall HH, Ma TS, Mann DL. Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 1995;96:1042-1052.
33. Li X, Moody MR, Engel D, Walker S, Clubb FJ Jr, Sivasubramanian N, Mann DL, Reid MB. Cardiac-specific overexpression oftumor necrosis factor-alpha causes oxidative stress and contractile dysfunction in mouse diaphragm. Circulation 2000;102: 1690-1696.
34. Mann DL. The effect of tumor necrosis factor-alpha on cardiac structure and function: A tale of two cytokines. J Card Fail 1996;2:S165-S172.
35. Mann DL. Stress activated cytokines and the heart. Cytokine Growth Factor Rev 1996;7: 341-354.
36. Chang HJ, Chung J,Choi BJ, Choi TY,Choi SY, Yoon MH, Hwang GS, Shin JH, Tahk SJ, Choi BI. The origin of proinflammatory cytokines in patients with idiopathic dilated cardiomyopathy. J Korean Med Sci 2003;18:791-796.
37. Tsutamoto T, Hisanaga T, Wada A, Maeda K, Ohnishi M, Fukai D, Mabuchi N, Sawaki M, Kinoshita M. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 1998;31:391-398.
38. Colombo PC, Banchs JE, Celaj S, Talreja A, Lachmann J, Malla S, DuBois NB, Ashton AW, Latif F, Jorde UP,Ware JA, LeJemtel TH. Endothelial cell activation in patients with decompensated heart failure. Circulation 2005;111:58-62.
39. Silverstein RL, Febbraio M. Cd36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal 2009;2:re3.
40. Zirlik A, Bavendiek U, Libby P, MacFarlane L, Gerdes N, Jagielska J, Ernst S, Aikawa M, Nakano H, Tsitsikov E, Schonbeck U. Traf-1,-2,-3,-5, and-6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of cd40l in endothelial cells. Arterioscler Thromb Vasc Biol 2007;27: 1101-1107.
41. Sun D, Novotny M, Bulek K, Liu C, Li X, Hamilton T. Treatment with il-17 prolongs the half-life of chemokine cxcl1 mRNA via the adaptor traf5 and the splicing-regulatory factor sf2 (asf). Nat Immunol 2011;12:853-860.
42. Barlera S, Tavazzi L, Franzosi MG, Marchioli R, Raimondi E, Masson S, Urso R, Lucci D, Nicolosi GL, Maggioni AP, Tognoni G. Predictors of mortality in 6975 patients with chronic heart failure in the gissi-hf trial: proposal for a nomogram. Circ Heart Fail 2012;6:31-9.
43. White JV, Ryjewski C. Chronic venous insufficiency. Perspect Vasc Surg Endovasc Ther 2005;17:319-327.